These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19922513)

  • 1. The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh.
    Guinness L; Vickerman P; Quayyum Z; Foss A; Watts C; Rodericks A; Azim T; Jana S; Kumaranayake L
    Addiction; 2010 Feb; 105(2):319-28. PubMed ID: 19922513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh?
    Foss AM; Watts CH; Vickerman P; Azim T; Guinness L; Ahmed M; Rodericks A; Jana S
    Addiction; 2007 Jan; 102(1):114-25. PubMed ID: 17207129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine.
    Vickerman P; Kumaranayake L; Balakireva O; Guinness L; Artyukh O; Semikop T; Yaremenko O; Watts C
    Sex Transm Dis; 2006 Oct; 33(10 Suppl):S89-102. PubMed ID: 16735956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus.
    Kumaranayake L; Vickerman P; Walker D; Samoshkin S; Romantzov V; Emelyanova Z; Zviagin V; Watts C
    Addiction; 2004 Dec; 99(12):1565-76. PubMed ID: 15585048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
    Alistar SS; Owens DK; Brandeau ML
    PLoS Med; 2011 Mar; 8(3):e1000423. PubMed ID: 21390264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics.
    Alistar SS; Owens DK; Brandeau ML
    PLoS One; 2014; 9(1):e86584. PubMed ID: 24489747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
    Islam MM; Conigrave KM
    Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiological impact and cost-effectiveness of HIV testing, antiretroviral treatment and harm reduction programs.
    Li J; Gilmour S; Zhang H; Koyanagi A; Shibuya K
    AIDS; 2012 Oct; 26(16):2069-78. PubMed ID: 22781221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme.
    Peak A; Rana S; Maharjan SH; Jolley D; Crofts N
    AIDS; 1995 Sep; 9(9):1067-70. PubMed ID: 8527080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?
    de Vos AS; van der Helm JJ; Matser A; Prins M; Kretzschmar ME
    Addiction; 2013 Jun; 108(6):1070-81. PubMed ID: 23347124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection drug use, HIV and the current response in selected low-income and middle-income countries.
    Bergenstrom AM; Abdul-Quader AS
    AIDS; 2010 Sep; 24 Suppl 3():S20-9. PubMed ID: 20926924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia.
    Long EF; Brandeau ML; Galvin CM; Vinichenko T; Tole SP; Schwartz A; Sanders GD; Owens DK
    AIDS; 2006 Nov; 20(17):2207-15. PubMed ID: 17086061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a longitudinal community HIV intervention targeting injecting drug users' stage of change for condom and bleach use.
    Jamner MS; Wolitski RJ; Corby NH
    Am J Health Promot; 1997; 12(1):15-24. PubMed ID: 10170430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.
    Wodak A; Cooney A
    Subst Use Misuse; 2006; 41(6-7):777-813. PubMed ID: 16809167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.
    Holtgrave DR; Pinkerton SD; Jones TS; Lurie P; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S133-8. PubMed ID: 9663636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of environmental-structural communication interventions for HIV prevention in the female sex industry in the Dominican Republic.
    Sweat M; Kerrigan D; Moreno L; Rosario S; Gomez B; Jerez H; Weiss E; Barrington C
    J Health Commun; 2006; 11 Suppl 2():123-42. PubMed ID: 17148102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.